RU94022269A - Состав аэрозоля, находящийся под давлением - Google Patents

Состав аэрозоля, находящийся под давлением

Info

Publication number
RU94022269A
RU94022269A RU94022269/14A RU94022269A RU94022269A RU 94022269 A RU94022269 A RU 94022269A RU 94022269/14 A RU94022269/14 A RU 94022269/14A RU 94022269 A RU94022269 A RU 94022269A RU 94022269 A RU94022269 A RU 94022269A
Authority
RU
Russia
Prior art keywords
aerosol composition
under pressure
composition under
units
hydrofluoroalkane
Prior art date
Application number
RU94022269/14A
Other languages
English (en)
Other versions
RU2122852C1 (ru
Inventor
Нагарбхай Мистри Суреш
Гибсон Марк
Original Assignee
Финоз ПЛС.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919120396A external-priority patent/GB9120396D0/en
Priority claimed from GB919120675A external-priority patent/GB9120675D0/en
Priority claimed from GB919124661A external-priority patent/GB9124661D0/en
Priority claimed from GB929203212A external-priority patent/GB9203212D0/en
Application filed by Финоз ПЛС. filed Critical Финоз ПЛС.
Priority claimed from PCT/GB1992/001749 external-priority patent/WO1993005765A1/en
Publication of RU94022269A publication Critical patent/RU94022269A/ru
Application granted granted Critical
Publication of RU2122852C1 publication Critical patent/RU2122852C1/ru

Links

Claims (1)

  1. Изобретение относится к составам аэрозолей, находящимся под давлением, в частности к медикаментам для ингаляции. Состав аэрозоля содержит сжиженный гидрофтороалкан, диспергируемый в нем порошкообразный медикамент и растворимый в указанном гидрофтороалкане полимер, причем полимер включает в себя повторяющиеся структурные единицы, представляющие собой алкидосодержащие единицы и единицы, содержащие сложный эфир карбоновой кислоты. Задачей настоящего изобретения являлось создание экологически чистого состава аэрозоля, в котором поддерживается необходимое для надежной работы давление и обеспечивается хорошая растворимость и стабилизация лекарственных препаратов.
RU94022269/14A 1991-09-25 1992-09-23 Состав аэрозоля, находящийся под давлением RU2122852C1 (ru)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB9120396.8 1991-09-25
GB919120396A GB9120396D0 (en) 1991-09-25 1991-09-25 Formulations
GB919120675A GB9120675D0 (en) 1991-09-28 1991-09-28 Formulation
GB9120675.5 1991-09-28
GB919124661A GB9124661D0 (en) 1991-11-19 1991-11-19 Formulations
GB9124661.1 1991-11-19
GB929203212A GB9203212D0 (en) 1992-02-14 1992-02-14 Pharmaceutical formulations
GB9203212.7 1992-02-14
PCT/GB1992/001749 WO1993005765A1 (en) 1991-09-25 1992-09-23 Pressurised aerosol compositions

Publications (2)

Publication Number Publication Date
RU94022269A true RU94022269A (ru) 1995-11-10
RU2122852C1 RU2122852C1 (ru) 1998-12-10

Family

ID=27450754

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94022269/14A RU2122852C1 (ru) 1991-09-25 1992-09-23 Состав аэрозоля, находящийся под давлением

Country Status (29)

Country Link
US (1) US6641800B1 (ru)
EP (2) EP0534731A1 (ru)
JP (1) JP3142136B2 (ru)
KR (1) KR100275426B1 (ru)
CN (1) CN1050285C (ru)
AT (1) ATE132739T1 (ru)
AU (1) AU654397B2 (ru)
BG (1) BG61752B1 (ru)
BR (1) BR9206549A (ru)
CA (1) CA2119932C (ru)
CZ (1) CZ282506B6 (ru)
DE (1) DE69207606T3 (ru)
DK (1) DK0605578T4 (ru)
ES (1) ES2082507T5 (ru)
FI (1) FI110407B (ru)
GR (2) GR3019098T3 (ru)
HK (1) HK1005564A1 (ru)
HU (2) HUT67480A (ru)
IL (1) IL103238A (ru)
MX (1) MX9205483A (ru)
MY (1) MY108309A (ru)
NO (1) NO307124B1 (ru)
NZ (1) NZ244439A (ru)
RO (1) RO114735B1 (ru)
RU (1) RU2122852C1 (ru)
SK (1) SK279456B6 (ru)
TW (1) TW216442B (ru)
UA (1) UA41873C2 (ru)
WO (1) WO1993005765A1 (ru)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
GB9214819D0 (en) * 1992-07-13 1992-08-26 Minnesota Mining & Mfg Valve assemblies
DE69405719T2 (de) * 1993-03-17 1998-01-15 Minnesota Mining & Mfg Aerosolzubereitung, enthaltend ein aus einem diol-disäure-derivat abgeleitetes dispergiermittel
CA2156408C (en) * 1993-03-17 2005-02-15 Daniel C. Duan Aerosol formulation containing a polyester dispersing aid
EE03509B2 (et) 1995-06-27 2015-02-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6540982B1 (en) * 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
AU2001252350A1 (en) * 2000-04-13 2001-10-30 Innovata Biomed Limited Medicaments for treating respiratory disorders comprising formoterol and fluticasone
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
DK1280520T4 (en) 2000-05-10 2018-06-25 Novartis Ag Phospholipid based powders for drug delivery
ME00220B (me) 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
SI1273292T1 (en) 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
US7544177B2 (en) * 2002-01-24 2009-06-09 The Regents Of The University Of California Aerosol device to deliver bioactive agent
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
GB0328630D0 (en) * 2003-12-10 2004-01-14 Medpharm Ltd Metered dose inhalation preparations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
US7994225B2 (en) * 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
EP1732527A2 (en) * 2004-03-17 2006-12-20 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
US20070031343A1 (en) * 2005-08-04 2007-02-08 Bonfour Charles A Iii Flavored medicinal inhalant
FR2895260B1 (fr) * 2005-12-23 2009-02-20 Servier Lab Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
AU2009244462B2 (en) 2008-05-06 2013-04-11 Cook Medical Technologies Llc Apparatus and methods for delivering therapeutic agents
MX2011004730A (es) * 2008-11-04 2011-05-30 Cipla Ltd Composicion farmaceutica en aerosol.
JP5631332B2 (ja) 2008-12-23 2014-11-26 クック メディカル テクノロジーズ エルエルシーＣｏｏｋ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ 治療薬を収容及び送達するための器械及び方法
US8118777B2 (en) 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US9101744B2 (en) 2009-05-29 2015-08-11 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
US9867931B2 (en) 2013-10-02 2018-01-16 Cook Medical Technologies Llc Therapeutic agents for delivery using a catheter and pressure source
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
GB201402513D0 (en) * 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
US11123282B2 (en) * 2015-10-23 2021-09-21 Basf Se Formulations with a controlled release of perfumes for dermal application
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US417295A (en) * 1889-12-17 Fabriken
AT274245B (de) 1967-05-17 1969-09-10 Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien
US4025635A (en) 1972-09-06 1977-05-24 Burroughs Wellcome Co. Cyclic sulphur compounds
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
EP0175671A1 (de) 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
ATE71520T1 (de) * 1986-03-10 1992-02-15 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
AU601176B2 (en) 1986-03-10 1990-09-06 Kurt Burghart Benzodiazepine aerosols
US4752466A (en) 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL95952A0 (en) 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
US5658549A (en) 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery

Similar Documents

Publication Publication Date Title
RU94022269A (ru) Состав аэрозоля, находящийся под давлением
ES2001512A6 (es) Procedimiento para la fabricacion de esteres totales y parciales del acido hialuronico
DK278288A (da) Frigivelsessystem til laegemiddel ved anvendelse i mundhulen og en fremgangsmaade til fremstilling af dette frigivelsesystem
TW216442B (en) Pressurised aerosol compositions
CA2009890A1 (en) Valproic acid
FI956228A0 (fi) Sisäänhengitykseen tarkoitettuja koostumuksia
DE69233150D1 (de) Fluorchlorkohlenwasserstoffreie Aerosolformulierungen
DK0616524T3 (da) Lægemidler
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
RS49803B (sr) Primena lekovitih preparata rastvorenih u vodi za dobijanje aerosolova bez potisnog gasa
DE69333187D1 (de) Oberflächenaktivmittelfreie Aerosolformulierungen enthaltend Beclomethasondipropionat
KR870700354A (ko) 기포성 아세틸살리실산 정제의 개선
HUP9603489A2 (hu) Gyógyszerkészítmény és eljárás előállítására
ES2174388T3 (es) Solucion liquida de medicamento para administracion oral.
JPS5750914A (en) Betamethasone external pharmaceutical
WO1999024016A8 (en) Emulsions for aerosolization and drug delivery
KR890000472A (ko) 화합물
JPH02304017A (ja) ヘアスプレー組成物
KR950016757A (ko) 약물중독 치료제 조성물
SE9601483D0 (sv) Beredning av komposition
RU93027376A (ru) Получение таблетки, содержащей интерферон-альфа, для энтерального применения и ее состав